Massachusetts General Hospital Cancer Center

https://www.massgeneral.org/cancer-center

 

Experts Discuss Choosing BTKis in CLL, Sequencing Therapy in NHL, and Treating HL

48 views
June 16, 2024

Chapters

Discussing BTKis Selection: Acalabrutinib & Zanubrutinib

00:00

Choosing Glofitamab & Epcoritamab in NHL Therapy

02:22

Molecular Testing & Pirtobrutinib in BTK Progression

04:09

Strategies for CAR Ineligible NHL Patients

06:31

Approach to Upfront CLL with P53 Mutation

08:34

Second Line Therapy After Relapse in Hodgkin Lymphoma

11:23

Frontline Treatment for P53 Mutated Mantle Cell Lymphoma

13:24

Comments 0
Login to view comments. Click here to Login